They have a pipeline of oncology antibody therapeutics. Their lead antibody candidate is olinvacimab.
| Contact Details | 2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil, HQ +82-42-863-2017 |
|---|
They have a pipeline of oncology antibody therapeutics. Their lead antibody candidate is olinvacimab.
| Contact Details | 2F, Research Building 2, 70, Yuseong-daero 1689 beon-gil, HQ +82-42-863-2017 |
|---|
